Fischer Medical Ventures Ltd
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
- Market Cap ₹ 5,480 Cr.
- Current Price ₹ 845
- High / Low ₹ 919 / 574
- Stock P/E 4,567
- Book Value ₹ 52.9
- Dividend Yield 0.00 %
- ROCE 1.07 %
- ROE 0.57 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 16.0 times its book value
- Promoter holding has decreased over last quarter: -1.01%
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.1.49 Cr.
- Company has high debtors of 251 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0 | 21 | 111 | |
| 0 | 19 | 108 | |
| Operating Profit | 0 | 2 | 3 |
| OPM % | 11% | 9% | 3% |
| 0 | 0 | 1 | |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 2 |
| Profit before tax | 0 | 2 | 2 |
| Tax % | 13% | 45% | |
| -0 | 2 | 1 | |
| EPS in Rs | -2.33 | 0.34 | 0.23 |
| Dividend Payout % | 0% | 0% | 18% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 428% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 73% |
| 5 Years: | 80% |
| 3 Years: | 161% |
| 1 Year: | 43% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.17 | 54 | 64 |
| Reserves | -0 | 28 | 274 |
| 1 | 2 | 85 | |
| 0 | 4 | 34 | |
| Total Liabilities | 0 | 86 | 457 |
| 0 | 15 | 24 | |
| CWIP | 0 | 0 | 1 |
| Investments | 0 | 1 | 11 |
| 0 | 70 | 422 | |
| Total Assets | 0 | 86 | 457 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -8 | -86 | ||
| -29 | -125 | ||
| 37 | 315 | ||
| Net Cash Flow | 1 | 103 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 345 | 398 | 251 |
| Inventory Days | 36 | ||
| Days Payable | 82 | ||
| Cash Conversion Cycle | 345 | 398 | 205 |
| Working Capital Days | 324 | 505 | 265 |
| ROCE % | 5% | 1% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
1d - $10M AI-powered portable X-ray TB eradication partnership in Indonesia over 2 years.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - JV partner NYB.AI wins top global AI award for drug discovery platform, boosting Fischer Medical Ventures' innovation profile.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - FMV partners with Jember, Indonesia for $10M AI X-ray TB eradication program over 2 years.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
9 Jul - Fischer Medical Ventures acquires Malacca property to develop integrated regional healthcare hub.
-
Announcement Under Regulation 30- Listing In NSE
9 Jul - Listing of 6.48 crore equity shares of Fischer Medical Ventures on NSE from July 10, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Dec 2024TranscriptNotesPPT
Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals